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Summary Urinary tract infections (UTIs) are a serious health problem affecting
millions of people each year. Infections of the urinary tract are the second most
common type of infection in the body. Catheterization of the urinary tract is the
most common factor, which predisposes the host to these infections. Catheter-
associated UTI (CAUTI) is responsible for 40% of nosocomial infections, making it
the most common cause of nosocomial infection. CAUTI accounts for more than 1
million cases in hospitals and nursing homes annually and often involve uropathogens
other than Escherichia coli. While the epidemiology and pathogenic mechanisms of
uropathogenic Escherichia coli have been extensively studied, little is known about
the pathogenesis of UTIs caused by other organisms like Pseudomonas aeruginosa.
Scanty available information regarding pathogenesis of UTIs caused by P. aerug-
inosa is an important bottleneck in developing effective preventive approaches.
The aim of this review is to summarize some of the advances made in the ﬁeld
of P. aeruginosa induced UTIs and draws attention of the workers that more basic
research at the level of pathogenesis is needed so that novel strategies can be
designed.
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Urinary tract infections (UTIs) are one of the
most common bacterial infections affecting humans
throughout their life span [1,2]. UTIs account for
more than 8 million visits to physician’s ofﬁces,
1.5 million emergency room visits, and 300,000
hospital admissions in the United States annually
[3,4]. UTIs are the second most common infec-
tion of any organ system and the most common
urological disease in the United States, with a
total annual cost of more than $3.5 billion [5].
These infections are more common in females
than in men. Incidence in women in the age of
20—40 years ranges from 25 to 30% whereas in
older women above 60 years of age it ranges
from 4 to 43% [6—8]. UTIs can be classiﬁed as
uncomplicated or complicated [9,10]. The rec-
ognized predisposing factors in complicated UTIs
are anatomic defects, vesicouretic reﬂux (VUR),
obstruction, surgery, metabolic diseases like dia-
betes mellitus and generalized immunosuppression
especially in patients of organ transplant [11—16].
Catheterization of urinary tract is one of the
most common factor which predisposes the host to
complicated UTIs [17—20]. Instillation of catheter
may lead to damage of mucosal layer, which
disrupts the natural barrier and allows bacte-
rial colonization [21]. Organisms can gain entry
via extraluminal route [22] by moving across
the outer lumen of catheter or by intraluminal
route by directly entering the interior of catheter
[23].
The organisms most commonly responsible for
catheter-associated UTIs are Escherichia coli, Pro-
teus mirabilis, Pseudomonas aeruginosa, Klebsiella
pneumoniae and Streptococcus faecalis [6,24—26].
In case of E. coli, the epidemiological, experimen-
tal and clinical studies have established the role of
multiple virulence factors of E. coli like adhesins
operative through type-I ﬁmbriae and P ﬁm-
briae, O serotypes, K1 capsule, serum resistance,
hemolysins, cytotoxic nectrotizing factor (CNF) and
siderophores (enterochelin and aerobactin) in rela-
tion to uncomplicated and complicated UTIs [2,27].
However, there is paucity of literature in relation
to pathogenesis of UTIs caused by P. aeruginosa.
e
p
d
v
H................................................... 108
espite advances in antimicrobial therapy, the mor-
ality and morbidity associated with P. aeruginosa
nduced UTIs remain signiﬁcantly high. This unfa-
orable outcome is due to our inability to develop
herapeutic strategies to prevent the disease which
n turn is due to incomplete understanding about
he pathogenesis of the disease. The aim of this
eview is to highlight some of the most important
dvances in understanding the pathogenesis of P.
eruginosa induced UTIs.
irulence factors of uropathogenic P.
eruginosa
. aeruginosa is the third most common pathogen
ssociated with hospital-acquired catheter-
ssociated UTIs [6]. Virulence of P. aeruginosa is
ultifactorial and has been attributed to cell-
ssociated factors like alginate, lipopolysaccharide
LPS), ﬂagellum, pilus and non-pilus adhesins as
ell as with exoenzymes or secretory virulence
actors like protease, elastase, phopholipase,
yocyanin, exotoxin A, exoenzyme S, hemolysins
rhamnolipids) and siderophores [28—31]. These
actors have been shown to play an important
ole in pathogenesis of P. aeruginosa induced
nfections like respiratory tract infections, burn
ound infections and keratitis [32—36]. However,
imited reports are available regarding role of these
irulence traits in urinary tract infections. Woods
t al. [36] showed high production of elastase
nd protease in strains isolated from urinary tract
nfections in comparison to isolates from other
nfections like burn wounds infection, skin wound
nfection and acute pneumonia. Quantitative
nalysis of elastase, phospholipase C, toxin A, and
xoenzyme S was assessed in P. aeruginosa strains
solated from wound infections, respiratory tract
nfections and urinary tract infections by Hamood
t al. [37] It was observed that most of the isolates
roduced all the four virulence traits. However
epending on infection site, the isolates produced
aried levels of these virulence determinants.
igh levels of elastase and phospholipase C were
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[igure 1 Photograph showing complete encrustation of
agniﬁcation showing rod shaped bacteria on the surfac
roduced by most isolates obtained from trachea,
rinary tract, and wounds. Signiﬁcantly higher
evels of toxin A was produced by wound isolates,
hile signiﬁcantly higher level of exoenzyme S
as produced by wound and urinary tract iso-
ates. It was observed that persistent infection
solates from different sites produce signiﬁcantly
igher levels of exoenzyme S. These workers
oncluded that elastase, phospholipase C, toxin
, and exoenzyme S are important virulence traits
hich help P. aeruginosa to cause a variety of
ersistent infections. Ciragil and Soyletir [38]
nvestigated relationship between production of
irulence traits and site of infection. These workers
solated P. aeruginosa strains from cystic ﬁbrosis
atients as well as from lungs, urine and blood
f non-cystic ﬁbrosis patients. It was observed
hat urinary isolates produced least amount of
lginate and maximum amount of alkaline protease
s compared to other isolates. Signiﬁcantly lower
evels of alkaline protease were observed in cystic
brosis isolates as compared to other isolates.
o signiﬁcant difference in elastase levels was
bserved among different strains of P. aeruginosa.
owever these workers observed no correlation
etween elaboration of virulence factors and
ite of infection. It was concluded that virulence
actors play an important role in pathogenesis of
nfections caused by P. aeruginosa. Visca et al. [39]
ssessed production of virulence determinants in P.
eruginosa strains isolated from patients suffering
rom urinary tract infections. It was observed that
ropathogenic strains of P. aeruginosa produced at
east one type of siderophore i.e. pyochelin and/or
yoverdin. However not all the uropathogenic
trains produced both siderophores. We reported
hat uroisolates of P. aeruginosa produce high
evels of alginate, siderophores, exoenzymes and
emolysin [40]. However uroisolates possessing
igh hemolytic property showed signiﬁcantly high
a
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[ry catheter by bioﬁlms of P. aeruginosa (A) and a higher
catheter (B).
enal bacterial counts and marked tissue damage
ompared to low producers indicating direct
ssociation between hemolysin production and
enal colonization. It was suggested that besides
onsidering levels of all extracellular enzymes,
igh levels of hemolysin production in vitro could
e used as surrogate information for assessing
yelonephritic potential of P. aeruginosa. Further
tudies employing mutant strains of P. aeruginosa
efective in hemolysin production are required to
lucidate the precise contribution of this virulence
rait to the incidence of UTIs.
ioﬁlm formation by P. aeruginosa
n addition to elaboration of virulence factors,
. aeruginosa has a tendency to form bioﬁlms on
he surface of urinary catheters. Growth of P.
eruginosa begins in the form of microcolonies,
hich later coalesce together to form bioﬁlms
Fig. 1) [41—43]. Alginate, which is an acetylated
olymer of beta-D-mannouronic acid and alpha-L-
uluronic acids, is the most important component
f P. aeruginosa bioﬁlms. However, some other
xopolysaccharides like psl and pel have also
een shown to play an important role in bioﬁlm
orming ability of non-alginate producing strains
f P. aeruginosa [44,45]. Psl is a mannose-rich and
alactose-rich polysaccharide, however the precise
sl structure has not been elucidated [46—50]. This
s an area requiring future research. As with Psl,
he Pel structure is unknown and further biochem-
cal analyses of Pel polysaccharide is necessary
51]. Bioﬁlms are resistant to antimicrobial agents
s well as to host defense mechanisms and hence
re difﬁcult to eradicate. Bioﬁlms contribute
owards pathogenicity of P. aeruginosa as these
ften lead to persistent and recurrent infections
52—54].
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Figure 2 (A) Photograph showing abscess (yellow arrow) and casts (white arrows) along with necrotic changes in renal
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ctissue of mice infected with bioﬁlm cells of P. aeruginos
(white arrow) of mice infected with planktonic cells of P.
this ﬁgure legend, the reader is referred to the web vers
Once an opportunistic pathogen like P. aerugi-
nosa enters the host, its ability to cause infection
has been correlated with its tendency to form
bioﬁlms [55,56]. P. aeruginosa has an innate
propensity to stick to the surfaces of catheters
and form bioﬁlms leading to higher incidence of
UTIs in patients with long-term indwelling bladder
catheterization [41,47—59]. In addition, previous
microbial urethral colonization could be the cause
of most UTIs where introduction of bacteria into
the bladder takes place subsequently at the time
of catheterization [23,60]. Besides disruption of
the normal valvular function of urethra, catheters
can also traumatize urethral and bladder mucosa,
hence disrupting the normal mucopolysaccharide
coating of the epithelium [61]. This damage of
cellular structure renders it susceptible to attach-
ment as well as entry of bacteria through surface
erosions [62,63]. Therefore, catheter serves as a
direct conduit for pathogens which may be car-
ried from the external meatus to the bladder
when the catheter is introduced [64]. In addi-
tion, internal and external surfaces of catheters
have intrinsic irregularities providing convenient
sites for organism’s implantation as demonstrated
by scanning electron microscopy [65]. Following
initial adherence, bacteria may exude or attract
some products to further solidify attachment [66].
Costerton et al. [67] related the pathogenesis
of catheter-associated UTIs to the production of
bioﬁlms by the infecting organisms in which bacte-
rial population adhered to catheter surface through
pili and/or exopolysaccharides. The organisms in
bioﬁlms are able to persist in host’s tissues for
longer durations and are able to cause continuous
damage to the host [52]. In vivo bioﬁlm formation
was reported by Nickel et al. [68] where coloniz-
ing bacterial population was observed embedded
in glycocalyx on the external and internal sur-
d
d
o
a) Photograph showing mild inﬂammation in renal tissue
ginosa. (For interpretation of the references to color in
f the article.)
aces of Foley’s catheter removed from patient.
anderton et al. [69] examined 50 Foley blad-
er catheters that had been indwelling for periods
anging from 3 to 83 days in patients for the
resence of bacterial bioﬁlms. Scanning electron
icroscopy revealed bioﬁlm formation on the lumi-
al surfaces of 44 of these catheters. These workers
bserved very thin to very thick bioﬁlms embedded
n a matrix. Stickler et al. [70] compared nature
f bioﬁlms formed in urease producing and non-
rease producing organisms. It was observed that
rease producing organisms, P. mirabilis, Proteus
ulgaris and Providencia rettgeri formed crystalline
ature of bioﬁlms whereas urease-negative bacte-
ia, Morganella morganii, Klebsiella pneumoniae
nd P. aeruginosa produced non-crystalline bioﬁlms
n urethral catheter. Similar observation of bioﬁlm
ormation in vivo by P. aeruginosa on indwelling
atheter in mice was made by Kurosaka et al.
71]. In their study, scanning electron microscopy
evealed a thick bioﬁlm formation on the surface
f polyethylene tubing from day 2 onwards which
radually increased till day 14. Repeatable pattern
f cell death and lysis has been documented to
ccur in bioﬁlms of P. aeruginosa during the normal
ourse of development. During the onset of bioﬁlm
evelopment and bioﬁlm killing thereafter, a bac-
eriophage capable of superinfecting and lysing the
. aeruginosa parent strain has been detected in
he ﬂuid efﬂuent from the bioﬁlm [72,73]. The bac-
eriophage implicated in bioﬁlm killing was closely
elated to the ﬁlamentous phage Pf1 which existed
s a prophage within the genome of P. aerugi-
osa. It has been proposed that prophage-mediated
ell death could be an important mechanism of
ifferentiation inside microcolonies that facilitate
ispersal of a subpopulation of surviving cells. From
ur laboratory we observed that bioﬁlm cells are
ble to cause more renal tissue damage compared
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irinary tract infections caused by Pseudomonas ae
o planktonic counterparts possibly through evasion
f phagocytosis and production of free radicals in
ouse model of ascending UTI (Fig. 2) [74]. Hence
ormation of bioﬁlms is the most important virulent
rait of P. aeruginosa which enables this pathogen
o cause recurrent and chronic UTIs by evading host
mmune defense mechanisms.
uorum-sensing in P. aeruginosa
variety of gram-negative and gram-positive bac-
eria have been reported to monitor their cell
ensity as well as expression of virulence fac-
ors through chemical signals. These signals known
s quorum-sensing signals are mainly operative
hrough autoinducers generally acylhomoserine lac-
ones (AHLs). In P. aeruginosa two types of
uorum-sensing systems, las [75] and rhl [76]
ave been reported which consist of two signal-
enerating synthetases (LasI RhlI) and two cognate
ranscriptional regulators (LasR RhlR). The major
roducts of LasI and RhlI are N-(3-oxododecanoyl)-
omoserine lactone (OdDHL or 3OC12-HSL) [77]
nd N-butanoylhomoserine lactone (BHL or C4-HSL)
78,79], respectively. The lasIR encoded quorum-
ensing system has been shown to modulate
xpression of lasI itself [80], lasB (elastase) [81,82],
lkaline protease [83], secretion pathway [84] and
hlR [85,86]. The rhlIR-encoded quorum sensor
odulates expression of rhlI itself [85], rhlAB
rhamnolipid biosynthesis) [76,82], lasB [78,82,87]
nd rpoS [85]. Both these quorum-sensing systems
re involved in the differentiation of planktonic
ells to bioﬁlm mode [88]. Role of these quorum-
ensing signals in virulence and pathogenicity of
. aeruginosa has been demonstrated in models of
espiratory tract infections, burn wound infections
nd keratitis [89—94]. However, very limited stud-
es highlighting the role of these signal molecules
n the pathogenesis of urinary tract infections are
vailable. Stickler and co-workers [69] reported
roduction of AHLs by P. aeruginosa isolated from
rethral catheters using cross-feeding assay. These
orkers demonstrated production of AHL molecules
n bioﬁlms in vitro as well as in vivo in the patient’s
ladder. Relatively recently from our laboratory, we
eported that quorum-sensing signals play a crucial
ole in ability of P. aeruginosa to cause urinary tract
nfection [95]. Single mutant harboring mutated las
gene and double mutant harboring mutated las
and rhl R as well as quorum deﬁcient clinical
train of P. aeruginosa were cleared from the renal
issues much earlier than parent strain possessing
unctional las and rhl quorum-sensing systems high-
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ighting central role of quorum-sensing signals in
irulence of P. aeruginosa. Recently some new types
f quorum-sensing systems like PQS and have been
dentiﬁed in P. aeruginosa however their role in UTIs
as yet to be elucidated [96—98].
nvironmental factors and urovirulence
f P. aeruginosa
. aeruginosa has been reported to continuously
ense and respond to various environmental
timuli. While establishing in the urinary tract,
resence of urine, which is a complex medium,
xposes invading organism to conditions like varied
smolarity, pH and Tamm—Horsfall protein (THP)
s well as variability of ions such as iron [99—101].
rine is subject to change in pH and osmolarity
epending on host’s diet and clinical situation.
nvironmental conditions prevalent in the host
ileu may bring about certain changes in organism
ike change in outer membrane protein (Omp)
roﬁle, porin size [102,103] and adhesive ability
perative through lectins [99,102,104] which may
lay an important role in deciding the ultimate
utcome of an infection.
ron
ron-limiting conditions have been reported to be
revalent in the milieu of urinary tract [100],
herefore the ability of uropathogens to sequester
ron from the host becomes a signiﬁcant factor
n determining their growth, metabolic process
nd pathogenicity [105]. P. aeruginosa has been
eported to produce two siderophores, pyochelin
nd pyoverdin, which help this pathogen to obtain
ron from host’s iron binding proteins like lacto-
errin and transferrin. In relation to P. aeruginosa
ome in vitro, studies are available where iron
as been shown to regulate production of toxin
[106], alkaline protease [107], elastase [99,107]
nd siderophores [99], the recognized virulence
actors of this opportunistic organism. Iron concen-
ration of the culture medium employed for growth
f P. aeruginosa was also shown to have the poten-
ial to inﬂuence pathogenicity of this organism
n corneal [108] as well as in the acute respira-
ory tract infection model [109]. Recent studies
rom our laboratory demonstrated that P. aerug-
nosa grown in iron deplete medium were more
irulent as compared to iron replete grown bacteria
s indicated by higher production of virulence fac-
ors and lodgement of bacteria in the urinary tract
f experimental animals [110]. Hence, existing
iterature indicate that levels of iron dictate vir-
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ulence of P. aeruginosa and are thus critical for its
pathogenicity. Extrapolation of available informa-
tion may help in developing alternative preventive
approach against UTIs based on iron supplementa-
tion with far reaching consequences.
Osmolarity
Osmolarity is another important factor which has
been reported to affect growth and virulence of
P. aeruginosa. In order to establish and cause
UTI, P. aeruginosa has to adapt itself to varia-
tions in osmolarity of urine. We observed that
osmolarity has profound inﬂuence on uroviru-
lence of P. aeruginosa [111]. There was signiﬁcant
increase in production of virulence factors with
increase in osmolarity from 200 to 300mOsmol/l.
However further increase in osmolarity led to sig-
niﬁcant decrease in production of virulence factors.
In addition, organisms grown in medium having
osmolarity 300mOsmol/l were resistant to phago-
cytosis and were more virulent in mouse model of
ascending UTI as indicated by signiﬁcantly higher
neutrophil recruitment, bacterial load, malondi-
aldehyde (MDA) production, a marker of tissue
damage, and renal as well as bladder pathology.
Culham et al. [112] highlighted that in addition to
directly inﬂuencing bacterial growth in the urinary
tract, osmoregulatory mechanisms may indirectly
inﬂuence urinary tract infection by affecting the
expression of virulence determinants. In case of
P. aeruginosa, the sigma factor, Rpo S, has been
shown to play an important role during exposure
of this organism to various environmental stresses
including osmotic stress. Suh et al. [101] also sug-
gested importance of Rpo S in the pathogenesis of
P. aeruginosa induced respiratory infections. There
is strong possibility that similar mechanism may be
operative in the urinary tract affecting the evolu-
tion of infection caused by P. aeruginosa although
this needs further conﬁrmation.
Tamm—Horsfall protein
In the urinary tract, complex urine provides a
medium which has copious amounts of mucus. The
urinary mucus predominantly has Tamm—Horsfall
protein (THP) which is a polymeric glycoprotein,
produced in thick ascending limb of loop of Henle
in renal tissue [113]. Majority of THP is in the form
of secreted protein in urine but it also exists in
membrane bound form especially at the renal dis-
tal nephron cell surface [114]. Concentration of
THP has been reported to be crucial in deciding
the ultimate role played by this protein [115]. We
observed that with increase in concentration of THP
p
c
n
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rom 10 to 50g/ml, there was gradual rise in elab-
ration of all the virulence factors as compared
o control (i.e. in absence of THP). However with
urther increase in concentration of THP from 50
o 70g/ml there was signiﬁcant fall in produc-
ion of all the virulence traits by bioﬁlm cells of P.
eruginosa [116]. Decreased uptake and intracellu-
ar killing of THP (50g/ml) coated planktonic and
ioﬁlm cells of P. aeruginosa by murine peritoneal
acrophages were also observed. In addition, it
as observed that THP coated P. aeruginosa cells
ere more virulent in vivo in UTI model, show-
ng higher level of destruction in kidney as well
s in bladder tissue in comparison to uncoated
rganisms [117]. These results therefore bring out
hat THP coating provide better opportunity to this
athogen for survival in vivo by evading phagocyto-
is. Hawthorn et al. [118] while comparing adhesion
f three uropathogens to THP coated renal tubular
ells in vitro, also stressed that THP may not help
o remove all uropathogens from urinary tract. It
ay help in renal colonization of uropathogens like
. aeruginosa. In the milieu of the kidney where THP
s available in abundance these observations have
mmense relevance. Once P. aeruginosa reaches
enal parenchyma, this ability may help this organ-
sm to colonize, get established and persist. Further
n vivo studies using THP knock-out mice are war-
anted which can shed more light on the precise
ole of THP in P. aeruginosa induced UTIs.
ost innate immune system and urinary
ract infections
esides environmental factors, the host also plays
n important role in the establishment of an infec-
ious process. Microbial virulence is dependent on
ost factors, as exempliﬁed by the pathogenic-
ty of avirulent microbes in immunocompromised
osts and the lack of pathogenicity of virulent
athogens in immune hosts. In this regard the
nnate immunity provides a ﬁrst line of defense
n which macrophages and neutrophils play an
mportant role. Macrophages, coming mostly from
irculation, form one of the initial lines of defense
n the urinary tract and offer resistance against
nfection. These macrophages interact with invad-
ng pathogen leading to elaboration of biochemical
ubstances referred to as macrophage secretory
roducts (MSPs). MSPs have been recognized to
ontain peptide hormones, complement compo-
ents, enzymes, bioactive oligopeptides and lipids,
eactive oxygen and nitrogen species as well as
ytokines [119]. P. aeruginosa has been reported
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Nrinary tract infections caused by Pseudomonas ae
o exploit these MSPs for its own growth and
nhancing production of virulence traits leading to
nhanced virulence in mouse model of ascending
TI (unpublished data) [120]. Utilization of MSPs by
. aeruginosa can have far reaching consequences
ncluding chronicity and recurrence of infections
aused by this pathogen. Since MSPs contain a
iverse array of biomolecules which can act in a
omplex manner among themselves, further stud-
es are warranted which can throw more light on
he precise role of MSPs in UTIs.
In addition to macrophages, neutrophils also
rovide defense against UTIs operative through
hagocytosis as well as elaboration of cytokines.
n one hand, these cells are essential for clear-
nce of bacteria from urinary tract, on the other
and neutrophils have been implicated in tissue
amage leading to renal scarring [121]. In case neu-
rophils are trapped and tissue is destroyed, the
idney pathology has been reported to be progress-
ng to the stage of chronicity and renal scarring.
hese cells are recruited to the site of infection
n response to chemokine secretion by bladder and
enal epithelial cells like IL-8. In vitro production
f IL-8 has been studied in cultured epithelial cells
rom various sources [122], where it has been shown
o affect neutrophil chemotaxis, degranulation and
ransendothelial migration. High levels of IL-8 have
een demonstrated in urine of patients suffer-
ng from UTIs. Macrophage inﬂammatory protein-2
MIP-2) is one of the human IL-8 homologues in the
ouse. Studies from our laboratory demonstrated
hat although bioﬁlm cells of P. aeruginosa induce
igher levels of MIP-2 compared to planktonic coun-
erparts leading to more recruitment of neutrophils
ut are resistant to killing by neutrophils possibly by
nterfering with oxidative burst capacity in mouse
odel of ascending UTI [9]. Thus the ultimate clear-
nce of the organism is not based on the collection
f neutrophils but the efﬁcacy of the neutrophils to
ill, especially bioﬁlm forms of P. aeruginosa.
UTIs activate both mucosal and systemic inﬂam-
atory responses in which cytokines play a pivotal
ole [123,124]. Cytokines, both proinﬂammatory
nd anti-inﬂammatory, have been reported to be
roduced largely by macrophages. In addition, wide
ariety of cells including lymphocytes, endothe-
ial cells, pulmonary epithelial cells and urinary
ract epithelial cells produce these cytokines in
esponse to bacteria [125] or their products like
ipopolysaccharide (LPS) and ﬁmbriae [126—128].
ytokines like TNF-, MIP-2, IL-6 and IL-1 have
een reported to be produced in urinary tract fol-
owing infection with uropathogenic E. coli which
elp in transepithelial migration of phagocytes from
lood to the site of infection [129,130]. Increased
a
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evels of these cytokines and their receptors have
een observed in urine and serum samples of
atients having acute pyelonephritis [131]. How-
ver there is paucity of literature in relation to role
f these cytokines in UTIs caused by P. aeruginosa.
ince cytokines play an important role in recruit-
ng immune cells to the site of infection, further
tudies in relation to UTIs are warranted, and will
e of special relevance for clinicians for treating
atheter- and hospital-acquired infections.
uture challenges
espite advances in antimicrobial therapy the mor-
ality and morbidity associated with P. aeruginosa
nduced UTIs still remains high. This unfavorable
utcome is due to our incomplete understanding
bout the pathogenesis of the disease. Very limited
tudies are available in relation to the pathogenesis
f P. aeruginosa induced UTI. This review draws
ttention of the researchers that there is need
o understand pathogenetic mechanisms of UTIs
aused by P. aeruginosa in order to design effective
reatment strategies. Acylhomoserine lactones
AHLs) can be speculated to serve as potential
arget molecules for inhibition of bioﬁlm forma-
ion. In addition, role of bacterial and host factors
uring evolution of urinary tract infection caused
y P. aeruginosa needs to be looked into since
uch infections, which may lead to persistence and
hronicity, posing a threat for a treating clinician.
ecognizing how P. aeruginosa overrun crucial host-
ell pathways by using a myriad of mechanisms
ay help in understanding pathogenesis of UTIs
aused by this pathogen. This knowledge needs
o be advanced to the point at which it can be
ranslated into a true understanding of the disease.
his remains the crucial challenge to all who are
nvolved in this ﬁeld. All this information may
elp in developing effective preventive strategies
gainst bioﬁlms of P. aeruginosa formed on urethral
atheters which are a major cause of recurrence,
ersistence and chronicity.
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